| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |